Manage your formulary budget
Proactively manage your pharmacy inventory
Drug patents …
… from Kazakhstan to Kalamazoo
Find generic entry opportunities
Anticipate generic drug launch
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Methods and apparatus for delivery of ocular implants|
|Abstract:||An apparatus and methods for delivering ocular implants or microimplants. The apparatus is ergonomically designed for ease of use, and a simple manual depression of an actuator produces proportional movement of a linkage causing the implant or microimplant to be ejected through a cannula disposed at the desired location in the eye. Small gauge cannulas are provided for self-sealing methods of delivery.|
|Inventor(s):||Weber; David (Danville, CA), Kane; Ingrid (Los Altos, CA), Rehal; Mike (Boulder Creek, CA), Lathrop, III; Robert L. (Santa Clara, CA), Aptekarev; Kenny (Santa Cruz, CA)|
|Assignee:||Allergan, Inc. (Irvine, CA)|
1. A method of delivering an ocular microimplant into a patient's eye comprising the steps of: (a) providing a cannula having a proximal end, a distal sharp end, and a lumen extending
therethrough, a microimplant retained within the lumen, and a push rod received through the proximal end of the cannula; (b) puncturing the outer layer of a patient's eye with the cannula and inserting the cannula into a patient's eye to a desired
location; (c) moving the push rod from the proximal end of the cannula toward the distal end of the cannula, thereby ejecting the microimplant from the cannula; and (d) removing the cannula and push rod from the patient's eye; wherein the puncture in
the patient's eye created by the insertion of the cannula in step (c) is self-sealing upon the removal of the cannula in step (d).
2. The method of claim 1 wherein the providing step (a) further comprises providing a cannula having an outer diameter of 0.032 inches or less.
3. The method of claim 1 wherein the providing step (a) further comprises providing a cannula having an outer diameter of approximately 0.028 inches or less.
4. The method of claim 1 wherein the providing step (a) further comprises providing a cannula wherein the cannula lumen has a cross-sectional area of 0.0008 square inches or less.
5. The method of any one of claims 1-4 wherein the puncturing step (b) further comprises inserting the cannula into the patient's eye at an angle of 45.degree. or less relative to the eye surface.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.